Erasme University Hospital

• Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases

  Phase 2, Recruiting, 70 people, 5 Jan 2024

• NCT05569772

  Collaborator, Phase 3, Recruiting, 252 people, 6 Oct 2022

• NCT04758936

  Phase 4, Status unknown, 50 people, 17 Feb 2021

• NCT04289805

  Phase 4, Terminated, 96 people, 28 Feb 2020

• The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients

  Collaborator, Phase 3, Active, not recruiting, 2,400 people, 15 Jun 2017

• NCT02958163

  Collaborator, Phase 2, Terminated, 3 people, 8 Nov 2016

• NCT02661932

  Phase 4, Completed, 65 people, 25 Jan 2016

• NCT01849016

  Collaborator, Phase 3, Completed, 96 people, 8 May 2013

• NCT00962442

  Phase 3, Completed, 44 people, 20 Aug 2009

• NCT00910390

  Completed, 584 people, 29 May 2009

• NCT00903188

  Collaborator, Phase 4, Status unknown, 152 people, 18 May 2009

Sources: clinicaltrials.gov